July 30, 2016 2:35 AM ET

Capital Markets

Company Overview of Wellcome Trust, Investment Division

Company Overview

Wellcome Trust, Investment Division is a private equity and venture capital firm specializing in equity financing in early stage companies, buyouts, absolute returns, and emerging markets. The firm also invests in venture capital funds and buyouts funds and also selectively invests in later-stage private companies. It prefers to invest in healthcare, life sciences, therapeutics, technologies, medical devices, financial services, and energy space. The firm typically invests in U.S. and Europe. It seeks to invest up to £10 million ($18.82 million) over the life of a company through initial and follow-on financings. The firm usually invests alongside venture capitalists that are represented on ...

215 Euston Road

Gibbs Building

London,  NW1 2BE

United Kingdom

Phone:

44 20 7611 8888

Fax:

44 20 7611 8545

Key Executives for Wellcome Trust, Investment Division

Chief Executive of Project Sigma
Managing Director and Member of Investment Committee
Chief Investment Officer and Member of Investment Committee
Age: 52
Investment Adviser
Compensation as of Fiscal Year 2016.

Wellcome Trust, Investment Division Key Developments

The Wellcome Trust Presents at BIO Trinity 2016, Apr-25-2016

The Wellcome Trust Presents at BIO Trinity 2016, Apr-25-2016 . Venue: Novotel London West, 1 Shortlands, London W6 8DR, United Kingdom.

The Wellcome Trust Presents at The HedgeFund Intelligence European Summit 2015, Apr-28-2015 11:35 AM

The Wellcome Trust Presents at The HedgeFund Intelligence European Summit 2015, Apr-28-2015 11:35 AM. Venue: Palais de la Bourse, Paris, France. Speakers: Richard Walters, Investment Manager.

H. Lundbeck A/S Announces Research Partnership for Treatment of Brain Diseases Involving Seven Universities

H. Lundbeck A/S has announced a new public-private partnership involving seven universities, for the treatment of brain diseases. Lundbeck is involved in new research that will investigate a novel link that could show a relationship between the immune system and mood disorders, such as depression, and neurodegenerative diseases, such as Alzheimer's disease. This project, a public-private partnership also involving The Wellcome Trust, Cambridge University and pharmaceutical company Janssen, may be the first step towards a new and significantly improved treatment for a broad range of brain diseases. The main theory that the project will investigate is that the immune system can worsen brain diseases like depression and Alzheimer's disease. An imbalance in the immune system of the brain can drive a permanent and unhealthy neuro-inflammation - or inflammation in the brain - that can contribute to or cause brain diseases. This new project is a public-private partnership between Lundbeck and Janssen, and seven universities. The project has received a strategic award valued at approximately DKK 50m from the Wellcome Trust. The project consists of two parts. The team will begin by investigating the immune systems of people with treatment-resistant depression and Alzheimer's disease. In this phase, researchers will seek to more precisely establish the relationship between immune-related biomarkers found in blood and brain including cytokines, which are small proteins that play an important role in the regulation of the immune responses. The second part of the research program, which is reliant on the success of the first, will focus on small experimental medicine trials, using re-purposed anti-inflammatory drugs in patients who have been identified according to their specific immunological profile or 'phenotype'.

Similar Private Companies By Industry

Company Name Region
@sipp plc Europe
3i plc Europe
A E Taylor Financial Services Limited Europe
A-List Equity Research Limited Europe
A. Anthony Corporate Limited Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 22, 2016
DoorDash, Inc.
Private Placement
January 6, 2016
Elastagen Pty Ltd.
Private Placement
September 29, 2015
Apitope International NV
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Wellcome Trust, Investment Division, please visit www.wellcome.ac.uk/Investments/index.htm. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.